SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I - Tender offer statement by Issuer:
SEC Accession No. 0001737287-22-000043
Filing Date
2022-06-21
Accepted
2022-06-21 09:05:10
Documents
24

Document Format Files

Seq Description Document Type Size
1 SC TO-I allo-20220621xsctoxi.htm SC TO-I 114655
2 EX-FILING FEES allo-20220621xsctoxixex107.htm EX-FILING FEES 19163
3 EX-99.(A)(1)(A) allo-20220621xsctoxixexa1a.htm EX-99.(A)(1)(A) 309386
4 EX-99.(A)(1)(B) allo-20220621xsctoxixexa1b.htm EX-99.(A)(1)(B) 12046
5 EX-99.(A)(1)(C) allo-20220621xsctoxixexa1c.htm EX-99.(A)(1)(C) 35906
6 EX-99.(A)(1)(D) allo-20220621xsctoxixexa1d.htm EX-99.(A)(1)(D) 12104
7 EX-99.(A)(1)(E) allo-20220621xsctoxixexa1e.htm EX-99.(A)(1)(E) 5672
8 EX-99.(A)(1)(F) allo-20220621xsctoxixexa1f.htm EX-99.(A)(1)(F) 6048
9 EX-99.(A)(1)(G) allo-20220621xsctoxixexa1g.htm EX-99.(A)(1)(G) 5268
10 EX-99.(A)(1)(H) allo-20220621xsctoxixexa1h.htm EX-99.(A)(1)(H) 4472
11 EX-99.(A)(1)(I) allo-20220621xsctoxixexa1i.htm EX-99.(A)(1)(I) 4688
12 EX-99.(A)(1)(J) allo-20220621xsctoxixexa1j.htm EX-99.(A)(1)(J) 4446
13 EX-99.(A)(1)(K) a11allo-20220621xsctoxix.htm EX-99.(A)(1)(K) 10319
14 a11allo-20220621xsctoxix001.jpg GRAPHIC 126795
15 a11allo-20220621xsctoxix002.jpg GRAPHIC 57254
16 a11allo-20220621xsctoxix003.jpg GRAPHIC 56252
17 a11allo-20220621xsctoxix004.jpg GRAPHIC 102097
18 a11allo-20220621xsctoxix005.jpg GRAPHIC 117358
19 a11allo-20220621xsctoxix006.jpg GRAPHIC 118508
20 a11allo-20220621xsctoxix007.jpg GRAPHIC 86748
21 a11allo-20220621xsctoxix008.jpg GRAPHIC 132308
22 a11allo-20220621xsctoxix009.jpg GRAPHIC 142794
23 a11allo-20220621xsctoxix010.jpg GRAPHIC 170083
24 a11allo-20220621xsctoxix011.jpg GRAPHIC 110389
  Complete submission text file 0001737287-22-000043.txt   2228000
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filed by) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC TO-I
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC TO-I | Act: 34 | File No.: 005-90685 | Film No.: 221026295
SIC: 2836 Biological Products, (No Diagnostic Substances)